Royal jelly alleviates gemcitabine-induced ovarian toxicity: an investigation on rat models

Kubra Tuğce Kalkan, Betul Yalcin, Halime Tozak Yildiz, Ertan Katirci, Eda Koseoglu, Demet Bolat, Arzu Yay

Open source

DOI
10.1186/s12906-025-05013-7
Published
2025-07-14
Container
BMC Complementary Medicine and Therapies
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12906-025-05013-7,
  title = {Royal jelly alleviates gemcitabine-induced ovarian toxicity: an investigation on rat models},
  author = {Kubra Tuğce Kalkan and Betul Yalcin and Halime Tozak Yildiz and Ertan Katirci and Eda Koseoglu and Demet Bolat and Arzu Yay},
  year = {2025},
  journal = {BMC Complementary Medicine and Therapies},
  doi = {10.1186/s12906-025-05013-7},
  url = {https://doi.org/10.1186/s12906-025-05013-7}
}

RIS

TY  - JOUR
TI  - Royal jelly alleviates gemcitabine-induced ovarian toxicity: an investigation on rat models
AU  - Kubra Tuğce Kalkan
AU  - Betul Yalcin
AU  - Halime Tozak Yildiz
AU  - Ertan Katirci
AU  - Eda Koseoglu
AU  - Demet Bolat
AU  - Arzu Yay
PY  - 2025
JO  - BMC Complementary Medicine and Therapies
DO  - 10.1186/s12906-025-05013-7
UR  - https://doi.org/10.1186/s12906-025-05013-7
ER  - 

APA

Kalkan, K. T., Yalcin, B., Yildiz, H. T., Katirci, E., Koseoglu, E., Bolat, D., & Yay, A. (2025). Royal jelly alleviates gemcitabine-induced ovarian toxicity: an investigation on rat models. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-025-05013-7

Source records